In the News - Q1 Productions

This Week’s Headlines

Google to Host Long-Term Clinical Study into Human Biology

Posted 4/19/2017

Google has announced an upcoming, long-term study into the lives of “healthy” adults. The 10,000 person study into human biology will be conducted by Verily, which was formerly known as Google Life Sciences. Points of interest in the study may be the correlation between sleep and blood test results, and particular proteins impacting cancer risks. The clinical study will further bridge the gap between technology and biological breakthroughs. Read the full article here.

FDA Approves First-Line Drug for Bladder Cancer

Posted 4/19/2017

Roche announced this week that its bladder cancer treatment, Tecentriq, has won FDA approval to treat advanced bladder cancer. The advanced approval decision makes Tecentriq the first pharmaceutical to be used as a first-line treatment of advanced bladder cancer. Tecentriq was the first drug to be approved in the treatment of bladder cancer. Roche is currently one of three companies testing approved bladder cancer treatment for other cancer therapies. Read the full article here.

Record Amount of FDA Drug Approvals in 2017

Posted 4/19/2017

The FDA has closed the first quarter of 2017 with a spike in drug approvals and endorsements. Over the last few months, the FDA has endorsed 13 drugs and officially approved 12 new drugs. This pace of approval tops recent years which have wavered between 6 and 10 approvals in the first quarter. This pace may slowdown in coming months, however, as the agency already has round 20 pending applications for pharmaceuticals and biologics for the coming year. Read the full press release here.

Lion Biotechnologies Partners with University of Texas for Lymphoma Trials

Posted 4/19/2017

Lion Biotechnologies has partnered with the University of Texas MD Anderson to conduct long-running clinical trials of its tumor-infiltrating lymphocyte in the treatment of ovarian cancer, pancreatic cancer, and various sarcomas. The trials will be conducted at MD Anderson, but will be designed by a Lion and MD Anderson steering committee. Lion is hoping to gain data showing promising treatment for many other kinds of cancers in the future. Read the full press release here.

UnitedHealth Cites Increase in Profit Outside of ACA

Posted 4/19/2017

UnitedHealth has announced an increase in profits since its departure from the Affordable Care Act. After leaving the healthcare act as a care payer, the insurance company has cited an overall increase in profits from the private market. Due to the increases in profit, the 2017 fiscal outlook is expected to reach $200 billion in annual revenue. UnitedHealth has used these increases as positive reasoning for leaving the healthcare system, and as protection for the uncertain future of the Affordable Care Act. Read the full article here.

At Veranex, we can help you with concept through to commercialization by enabling:
• Accelerated speed to market
• Controlled development costs
• Development risk mitigation
• Market viability assessment

At every stage, we navigate our clients to realize efficiencies in cost and time with our integrated and comprehensive solutions.

Visit Sponsor Website

Since TrainingPros was founded in 1997, we have been dedicated to helping our clients find the right consultant for their projects. 25 years later, we are proud to have helped hundreds of clients complete their projects and thousands of consultants find great assignments. We continue to focus on helping our clients and consultants as well as our community as a certified women-owned, award-winning staffing company that works exclusively with Learning & Development professionals to match consultants to client projects.

Visit Sponsor Website

TELCOR is the proven leader of health care software solutions for revenue cycle management (RCM) software and services designed specifically for laboratories. TELCOR RCM, our SaaS solution, and TELCOR Revenue Cycle Services, our billing service, are designed to streamline workflow, improve collections, and provide real-time analytics. Our software and service solutions are designed for the unique challenges and requirements of laboratory specialties and the clients they serve. With full access to data, labs have complete visibility of their data and can track key performance indicators. No other vendor works as hard ensuring you get paid for the work you do.

Visit Sponsor Website

At Tipping Point Media, we pride ourselves on developing innovative, creative, and technically advanced virtual training and digital marketing solutions for the life sciences industry.

We push the limits of what's possible using Augmented and Virtual Reality to create revolutionary experiences proven to increase audience engagement and retention rates.

Our dedicated team of educators, medical experts, certified programmers, and digital renaissance innovators are committed to creating high-quality custom creations that bring your company's vision to life.

Visit Sponsor Website

VantagePoint Performance trains Salespeople to be more fluent and comfortable across different situations needing different sales approaches, and we train Sales Managers to be better coaches and team leaders, with more focus and less stress.

We’re different from the average sales training company because:

We don’t believe that one approach, one system, or one methodology is absolutely superior. All have something to offer, and the “best approach” or “best system” depends on the sales situation. This is what our applied, academic research tells us.
Our use of data science, specifically Machine Learning, helps us learn about our clients more meaningfully. We provide insights from each client’s data to help them understand what drives the success of their top-performing Salespeople and Sales Managers.
We are constantly feeding what we learn back into our training products, and we invest a bigger slice of our total energy into this innovation than the average sales training company. Our clients can access always-refreshed intellectual property and content through our training subscriptions.

Visit Sponsor Website

Policy Reporter, acquired by TrialCard in 2019, provides innovative healthcare software solutions to track payer policies in near real-time and enhances market access for the therapies patients need most. The company’s patented software-driven solutions include a suite of billing and reimbursement tools for providers and laboratories, market intelligence tools for payers, and a suite of market access solutions for life science companies. Its clients include some of the world’s largest pharmaceutical and healthcare companies.

Visit Sponsor Website